Found 7 matching trials
Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma
PHASE2The hope is that the peptide vaccines will stimulate the immune system to a...
Location
University of Arkansas for Medical Sciences/MIRT
Tumor Markers Study in Gastric Cancer for Cancer Immunotherapy (ONCO-RD 010 CRT)
N/AGastric cancer is one of the leading causes of cancer-related deaths worldw...
Location
Multiple Locations
A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1
PHASE1This clinical trial is looking at two new vaccines called ChAdOx1-MAGEA3-NY...
Location
Blackpool Victoria Hospital
Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes
PHASE2Lung cancer is the worldwide leading cause of cancer death. In France, with...
Location
Institut Gustave Roussy
Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AML
PHASE1The purpose of this phase I study is to investigate the combination of hypo...
Location
Dept of Hematology, Herlev Hospital
Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma
PHASE1The purpose of this study is to achieving a six-month progression free surv...
Location
N. N. Petrov Research Institute of oncology
Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients
PHASE1The purpose of this study is to determine whether vaccination with tumor an...
Location
Oncology Department, CHUV